ClavystBio
ClavystBio and A*STAR partner to grow MedTech ventures in Singapore
ClavystBio, a life sciences investor and venture builder established by Temasek, and the Agency for Science, Technology and Research (A*STAR), Singapore's lead public sector research and development (R&D) agency, have signed a memorandum of understanding (MoU) to create and grow MedTech ventures in Singapore.
June 11, 2025
Singapore’s Oryon joins OpenAI SMB channel for ChatGPT Business
September 7, 2026
Singapore’s Oryon joins OpenAI SMB channel for ChatGPT Business
September 7, 2026




